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Abstract 
This is an up-to-date review on Chronic Intestinal Failure (CIF) and Parenteral Nutrition (PN) as 
a management strategy for CIF. 
CIF and long-term PN are important subjects, but are superficially covered in undergraduate 
curricula due to the perception that they are relatively specialist areas. PN, as well as being a form 
of acute nutritional support, is used as a life-sustaining measure for patients with CIF due to 
conditions such as bowel ischaemia and Crohn’s disease. Currently, around 500 patients receive 
long-term PN in the UK and the numbers are expected to rise with the aging population1. It is a 
costly service, requiring a multidisciplinary team effort, along with high frequency patient-
healthcare interaction. 
This article aims to discuss the current evidence on the causes, management and prognosis of 
CIF, with a particular focus on PN as a form of nutritional management. While PN seems to 
improve the prognosis of patients with CIF from a medical point of view, we will also explore 
how it affects other aspects of a patient’s life, such as their social life and mental health.  
 
 
 
Copyright Royal Medical Society. All rights reserved. The copyright is retained by the author and the Royal Medical Society, 
except where explicitly otherwise stated. Scans have been produced by the Digital Imaging Unit at Edinburgh University Library. 
Res Medica is supported by the University of Edinburgh’s Journal Hosting Service: http://journals.ed.ac.uk 
 
ISSN: 2051-7580 (Online)   ISBN: 0482-3206 (Print)     
Res Medicais published by the Royal Medical Society, 5/5 Bristo Square, Edinburgh, EH8 9AL 
 
Res Medica, 2014, 22(1): 37-50. 
doi:10.2218/resmedica.v22i1.813   
 Res Medica 2014, Volume 22, Issue 1        
Park, E et al. Who Needs a Gut Anyway? Res Medica 2014, 22(1), pp. 37-50. doi:10.2218/resmedica.v22i1.813  
37 
Who Needs a Gut Anyway? 
Introduction 
This is an up-to-date review on chronic 
intestinal failure (CIF) and parenteral 
nutrition (PN) as a management strategy for 
CIF.  
CIF and long-term PN are important 
subjects but not covered in detail at the 
undergraduate level due to the perception 
that it is a relatively specialist area within 
gastroenterology. However, it is an essential 
aspect of gastroenterology, which must be 
appreciated and understood by the medical 
student, particularly because of its associated 
mortality and morbidity. As well as being a 
form of acute nutritional support, PN is 
used as a life-sustaining measure for patients 
with CIF due to conditions such as bowel 
ischaemia and Crohn’s disease (CD). In the 
UK, there are currently around 500 patients 
receiving long-term home parenteral 
nutrition (HPN) in addition to oral nutrition 
and artificial enteral nutrition (EN), and the 
numbers are expected to rise with the ageing 
population.1It is a costly service requiring a 
multidisciplinary team effort along with high 
frequency patient-healthcare interaction. We 
will discuss the current evidence on the 
causes, management, and prognosis of CIF, 
with a particular focus on PN as a form of 
nutritional management. While PN seems to 
improve the prognosis of patients with CIF 
from a medical point of view, we will also 
explore how it affects other aspects of a 
patient’s life, such as their social life and 
mental health.  
Methods 
Articles on CIF were found through 
PubMed, MEDLINE, and Google Scholar, 
their abstracts reviewed and then selected 
on the basis of their relevance. The 
following is an example of a search strategy 
using MeSH headings on Ovid: 
1. exp “Parenteral Nutrition, Total”/ or exp 
“Parenteral Nutrition”/ (21019) 
2. exp “Quality of Life”/ (113933) 
3. 1 and 2 (333) 
4. exp “Parenteral Nutrition, Home”/ (940) 
5. 2 and 4 (161) 
Limited knowledge of total parenteral 
nutrition (TPN) meant that background 
reading and meetings with experts in the 
field had to be undertaken. A meeting was 
organized with a specialist nurse who 
provided background information on the 
use of TPN in NHS Lothian. 
Review articles were useful in providing 
links to relevant primary literature. 
References for both primary and secondary 
literature were shared and organized on an 
online group which was set up on Zotero.  
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Chronic intestinal failure 
Chronic intestinal failure (CIF) is defined as 
the long-term inability to sustain 
development and growth through oral 
nutrition,2 or the inability to maintain 
protein-energy, fluid, electrolyte, or 
micronutrient balance.3 The jejunum and 
ileum are the main absorptive surfaces of 
the gastrointestinal tract, although iron and 
calcium are preferentially absorbed in the 
duodenum. Jejunum and ileum absorb and 
process most of the ingested nutrients 
including amino acids, glucose, fat, 
electrolytes, vitamins, and bile salts. 
Approximately 1 m of functioning small 
intestine must remain to allow adequate 
absorption of nutrients. Surgery or disease 
that leaves less than this causes short bowel 
syndrome (SBS) and intestinal failure.4 
Chronic intestinal failure was considered a 
fatal state or one with poor prognosis, 
before life-saving techniques such as 
artificial enteral nutrition (EN), parenteral 
nutritional (PN) support, and bowel 
transplant surgery were developed.2 Such 
treatments have given CIF patients a better 
prognosis, although complications and side 
effects, such as diarrhoea, infections, and 
sepsis, may occur.5 
Causes of CIF 
Causes of CIF include congenital defects, 
dysmotility, obstruction, surgical resection, 
or disease-associated loss of absorption3,5 
The most common causes are SBS and 
motility disorders. 
SBS, which may result from congenital 
abnormalities or bowel resection, is the 
most common cause of CIF.6,7 In 1993, a 
multicentre survey in Europe showed that 
SBS represents the largest subset of patients 
(35%) that require HPN.8 The length of the 
small intestine in healthy state ranges from 
275 to 400 cm.6 SBS occurs when less than 
200 cm of small bowel remains.8 A study 
conducted by Nightingale et al.9 showed that 
the most common underlying diagnosis of 
SBS is CD; a relapsing inflammatory disease 
in which 50% of patients experience 
intestinal complications within 20 years.10 
Patients with a jejunostomy and a jejunal 
length of less than 100 cm are more likely to 
need long-term parenteral support due to 
excessive secretory loss.11 However, oral 
nutrition is usually sufficient for patients 
with 50 cm or more of small intestine if the 
colon is intact and remains in continuity.6 
Chronic intestinal failure can also arise from 
motility disorders such as extended 
Hirschsprung’s disease and chronic 
intestinal pseudo-obstruction (CIPO). CIPO 
is a rare, disabling disorder in which total 
bowel length remains normal, but its 
function is compromised by an impairment 
of gastrointestinal peristalsis that mimics 
mechanical obstruction.12 
Predominant causes of CIF in children are 
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congenital disorders such as intestinal 
atresia, gastroschisis, and microvillus 
atrophy.5,7 Other causes of CIF include 
small-bowel tumour and irradiation.7 
Artificial enteral nutrition 
Artificial EN involves the provision of 
nutrients through the gastrointestinal tract 
and is given when a patient cannot ingest, 
chew, or swallow food, but can still digest 
and absorb nutrients.13 EN is a common 
method of nutritional supplementation for 
patients with intestinal failure, both in 
hospitals and the community.14 
Indications 
EN is used in patients with a partially 
functioning gastrointestinal tract due to 
both chronic and acute conditions, and 
ensures that they receive sufficient nutrition 
while simultaneously stimulating the bowel 
during recovery.14 Artificial EN is the first-
line nutritional support for critically ill 
patients in general as well as for those who 
have undergone surgery.15 It is 
recommended that these patients should 
receive EN as tolerated, and PN only when 
EN does not meet the requirements for 
longer than several days to a week, 
depending on the previous nutritional 
state16; this also applies to paediatric 
patients.17 
 
Benefits 
Several reviews suggest that EN, rather than 
PN or surgery, is the preferred method of 
countering malnutrition in acute and chronic 
intestinal failure.16,18 Parenteral nutrition is 
costly, invasive, and associated with 
physical, social, and mental complications.19 
For example, the lack of exposure to 
nutrients and the resulting diminished 
release of bile and enzymes causes atrophy 
and inflammation of the intestine, which in 
turn leads to fatty liver and elevation of liver 
enzymes.4,18 This is more significant when 
part of the bowel is bypassed. There is also 
increased infection risk when nutrient-rich 
solutions are directly infused into the 
bloodstream.4There is open access from the 
skin into the bloodstream, which increases 
the risk of developing bloodstream 
infections, especially with skin flora. 
Compared with EN, intestinal 
transplantation is costly and associated with 
high morbidity and mortality.19 
Although septic complications due to the 
translocation of bacteria or bacterial 
products across a starving atrophied 
intestinal mucosa have been frequently 
reported, these are less likely to occur with 
EN.20 Furthermore, probiotics in feeding 
solutions have been claimed to support the 
growth of beneficial intestinal microflora 
but this is still an area of investigation.18 
Kompan et al.21 conducted a prospective, 
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randomized controlled trial involving 28 
patients who were treated in intensive care 
for multiple injuries. They found that 
patients who started EN immediately after 
admission were less likely to develop 
multiple organ failure and intestinal 
permeability than patients starting EN after 
24 hours. This study was limited due to a 
small sample size and the absence of 
blinding. The cause of illness and extent of 
damage to patients before treatment may 
also have varied greatly. Many studies have 
provided data suggesting that early EN may 
have beneficial effects on successful 
coverage of nutritional requirements, 
infectious complications, and length of stay 
in the ICU or hospital. 
Where possible, and clinically indicated, EN 
should be employed. Even in intestinal 
failure, it is advantageous to give continuous 
EN at slow speed. Sometimes, patients eat 
small meals 5 or 6 times a day and, if 
insufficient, they may receive supplementary 
nocturnal tube feeding. Complementary PN 
is indicated in cases where the above 
measures fail. 
Administration 
There are several ways to access the 
stomach and intestines in EN. The less 
invasive methods involve nasogastric, 
nasoduodenal, and nasojejunal tubes (Figure 
1). These methods are used for short-term 
EN or when the physical condition of the 
patient makes it unsafe to perform more 
invasive procedures. Nasal tubes can be 
inserted and advanced down into the 
stomach, the duodenum, or the jejunum. 
The feed is administered continuously (small 
amount of feed given without break 
throughout the day) or cyclically (for 
instance, every 12 or 24 hours).  
Figure 1: Routes of Administration (Adapted 
from Reinstein et al. 47) 
 
The decision of whether to use continuous 
or cyclical feeding depends on the patient’s 
physical condition, nutritional requirements, 
and degree of rehabilitation.22 Patients with 
CIF who are still able to absorb part of their 
nutritional requirements can cover their 
needs with additional nocturnal tube 
feeding. Some patients insert a thin 
nasogastric tube themselves and remove the 
tube during the day successfully with 
training. A more invasive method of EN 
involves enterostomy feeding tubes. 
Gastrostomy or jejunostomy feeding 
involves accessing the stomach or the 
jejunum endoscopically and inserting a tube 
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directly through the gastric or jejunal and 
abdominal wall. Enterostomy feeding tubes 
are mostly used when EN is required for at 
least 8 weeks and when the patient is in a 
suitable condition for a more invasive 
procedure.22 Cachectic patients should not 
receive enterostomy tubes because of a 
strongly elevated risk of leakage of nutrients 
into the abdominal cavity. This is due to the 
lack of adhesion of the stomach or jejunum 
to the inner side of the abdominal wall in 
truly cachectic states. 
Invasive and less invasive methods of EN 
exist to provide nutritional support for 
patients with relatively intact gastrointestinal 
organs in a more physiological way. 
Guidelines on different EN regimens are 
constantly being updated.22 
Complications 
There is a risk of feeding tube displacement 
in EN.Therefore, a small aspirate sample of 
gastric or intestinal fluid is taken to check 
the position of the tube end before 
administering any fluid. Nasogastric feeding 
can be associated with “dumping 
syndrome”, which occurs when the patient 
is suddenly overloaded with feeding 
formula. This happens when the tube 
bypasses the stomach, which normally acts 
as a reservoir for large volumes of food 
entering the gastrointestinal system.22,23 
 
Parenteral nutrition 
Parenteral nutrition is a form of nutritional 
support for severely malnourished patients 
who cannot be fed adequately by oral or 
enteral feeding. In contrast to enteral 
feeding, the nutrients are administered 
intravenously. Parenteral nutrition that 
provides total nutrition including protein, 
vitamins, energy, electrolytes, and trace 
elements is referred to as total parenteral 
nutrition (TPN) (Figure 2).5,24  
Figure 2. Total Parenteral Nutrition48 
 
Patients requiring long-term parenteral 
nutrition may be treated at home. Patients 
must receive training and they or a family 
member should be competent in managing 
home parenteral nutrition (HPN) feeding 
procedures.25 They are supported by 
specialist nutrition nurses and dieticians and 
are informed of potential complications.26 
Medical problems should be managed by a 
dedicated physician, closely working 
together with other members of a 
nutritional support team consisting of 
physicians, surgeons, dieticians, nurses, and 
pharmacists. Physiotherapists and 
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psychologists also contribute to the care of 
patients requiring nutritional support. The 
nutritional support team plays a crucial role 
throughout the duration of patients’ 
treatment with PN. The team follows the 
patients closely from the beginning of their 
training for PN administration to the rest of 
their treatment to ensure that PN is being 
administered safely and providing sufficient 
amount of nutrients. They play a significant 
role in providing patients and families with 
necessary mental and emotional support as 
well as supporting their physical health 
needs. 
Indication 
Parenteral nutrition is indicated for patients 
with either acute or chronic intestinal failure, 
in cases where they cannot receive or 
tolerate enteral feeding. Acute conditions 
include functional obstruction of the 
gastrointestinal tract (e.g. paralytic ileus), 
abdominal sepsis, and acid–base, electrolyte, 
or mineral imbalance. Parenteral nutrition is 
sometimes only required until intestinal 
function has recovered sufficiently for 
patients to meet their full nutritional 
requirements by oral or enteral route.5,24 
Composition of PN solutions 
Solutions for PN may be adjusted to each 
patient’s requirement, but most patients use 
standardized PN solutions.5,24 Each 
standardized PN solution usually comes in a 
2–3 L bag containing a balanced mixture of 
essential and non-essential amino acids, 
glucose, fat, electrolytes, trace elements, and 
vitamins. It typically provides 1800–
2500 kcal of energy and 10–14 g of 
nitrogen.5,24,27 Standardized PN solutions are 
supplied by the industry. However, 
customized PN solutions may differ in 
composition, depending on the patient’s 
nutritional requirements.27When not 
supplied by the industry, PN solutions are 
usually and preferably made under sterile 
conditions in the pharmacy. 
Administration 
Parenteral nutrition solutions are 
administered intravenously into a large 
central vein with a high blood flow, 
normally into the superior vena cava (SVC). 
This is to minimize damage to the vessel 
wall resulting from the solution’s high 
osmolarity. In smaller veins, the 
endothelium will rapidly become irritated by 
the hyperosmolar PN-mixture, leading to 
inflammation (phlebitis), which often results 
in secondary thrombosis and infection, 
unless the catheter is inserted in a peripheral 
vein but threading the tip of the catheter 
into the superior caval vein.27Catheter-
related blood stream infections need to be 
prevented by employing strict aseptic 
techniques during insertion and care of the 
catheter. Access to the SVC is generally 
obtained through the subclavian vein or 
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indirectly via a peripherally inserted central 
line. The position of the catheter is checked 
by radiography or ultrasound, and a 
(computerized) pump is connected to the 
catheter and the PN solution bag. In long-
term HPN, the pump controls the volume 
of nutrients administered over 12–15 hours, 
and it is claimed that this prevents metabolic 
disturbances while allowing mobility of the 
individual during the remainder of the 
day.5,24 
Complications 
1. Infection 
A clinical trial of 395 patients undergoing 
surgery showed that infection is one of the 
most frequent complications of PN, 
occurring in 14.1% of patients, with 
Staphylococcus aureus and coliforms being the 
most common infectious organisms.28 
Infection specifically occurred in mildly 
malnourished patients. Benefits of PN were 
only observed in severely malnourished 
patients, who exhibited fewer infectious 
complications than the control group. 
Infection rates increase when care of the 
feeding line and the insertion site is poor.  
2. Catheter-related problems 
Insertion of the venous catheter may 
damage structures adjacent to the veins, 
such as the pleural membrane and other 
smaller veins, causing pneumothorax and 
haematoma.27 However, in contrast to 
infection, a prospective single-centre study 
by Cotogni et al.29 showed that catheter 
dislocation is uncommon and occurred in 
only 5% of patients.  
3. Thrombophlebitis 
Thrombophlebitis refers to the 
inflammation of the vein leading to 
thrombus formation. It is common in PN 
patients, especially if the catheter is inserted 
into a vein with low blood flow. Signs of 
thrombophlebitis are erythema and 
tenderness over the area of the cannulated 
vein. If major thrombophlebitis is 
suspected, an ultrasound is performed to 
confirm the diagnosis, and anticoagulants 
such as heparin, urokinase, or plasminogen 
activator can be administered to dissolve the 
clot.5If unresolved, a new catheter is inserted 
into a healthy vein. 
4. Metabolic complications 
The most common metabolic complication 
in PN is hyperglycaemia. This is treated 
either by replacing 30% of glucose calories 
with fat or preferably with insulin 
treatment.30 Other metabolic complications 
include hypokalaemia and 
hypophosphataemia, which are common in 
severely malnourished patients who are 
refed after a long period of starvation.5,24 
5. Reduced quality of life 
Studies on the quality of life (QoL) of PN 
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patients provide conflicting evidence. 
Patients’ accounts vary greatly, depending 
on the severity of their complications and 
family environment.27In a study conducted 
in 48 HPN patients by Persoon et al.31 
involving surveys and structured open-
ended interviews, 92% reported at least one 
psychosocial problem while 50% reported at 
least one physical problem. A review of 38 
articles by Baxter et al.32 investigated the 
QoL of patients receiving HPN due to 
underlying diseases such as cancer or 
intestinal failure. Collectively, this showed a 
mixture of positive and negative impacts of 
HPN on aspects such as emotional function, 
social function, nutritional status, and 
employment status. The different impact of 
HPN on QoL depends on the severity of 
the underlying indication for their HPN.32 
6. Negative emotions 
A non-structured interview study showed 
that a third of HPN patients experience 
anxiety with regard to treatment 
complications.33 They may also feel anger 
and grief when others are unable to 
understand their condition.28 Another study 
demonstrated that 80% of HPN patients 
experience depression as a consequence of 
losing their social life, independence, and 
physical mobility. Additionally, they 
experience problems with care providers 
and other complications of HPN.26 
 
Intestinal transplantation 
Intestinal transplantation consists of the 
implantation of an intestinal allograft in 
patients with CIF, with the intention of 
restoring intestinal function.34  
Figure 3. Intestinal Transplantation (Adapted 
from Nickkholgh et al.49) 
 
Indications 
Intestinal transplantation is considered to be 
the most appropriate alternative to PN once 
PN-associated complications arise. On the 
basis of a prospective 5-year study in which 
the survival rates and causes of death of 
HPN patients were investigated, it was 
concluded that desmoids (fibrous 
neoplasms) and complications of HPN are 
the key indicators for life-saving intestinal 
transplantation.35 However, absolute criteria 
for intestinal transplantation are still under 
debate and not defined. 
Operative techniques 
Various operative techniques are used for 
intestinal transplantation, each selected 
according to the specific needs of the 
individual patient. 
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The most common procedure, usually used 
for adults, consists of transplantation of an 
isolated segment of small bowel. It is used 
for patients with CIF and preserved liver 
function, whereby the entire small bowel 
and the colon (if unhealthy) is resected 
down to the pelvic brim. Intestinal and 
vascular anastomoses are then made and an 
ileostomy is performed to allow post-
operative follow-up.36 
Children often require a combined liver and 
small-bowel transplant as a result of the 
presence of severe or even end-stage liver 
disease,37 which usually occurred in children 
with SBS due to necrotizing enterocolitis, 
especially in premature babies. In a study 
that analysed a registry data of 923 intestinal 
transplantation patients, it was found that 
55% of adults received intestinal transplants 
alone compared with 37% of children under 
18 years old. While a spread of ages is not 
provided in this study, data were acquired 
from 61 programmes, suggesting that the 
study included a representative sample of 
patients.38 Besides children, combined liver 
and small-bowel transplantation is also given 
to adults with intestinal failure or end-stage 
liver failure due to long-term PN. Those 
with concomitant liver failure and 
portomesenteric thrombosis may also be 
candidates for such treatment. Combined 
liver and small-bowel transplantation can 
either be performed with organs from the 
same donor or from 2 separate donors for 
each organ. In smaller patients, a combined 
reduced-size liver and small-bowel graft 
including the left, right, or extended right 
lobes of the liver may be of benefit.37 
Multivisceral transplantation (the 
transplantation of 3 or more abdominal 
organs en bloc)39 is indicated for patients 
with complex abdominal pathology, such as 
massive gastrointestinal polyposis, traumatic 
loss of the abdominal viscera, and extensive 
abdominal desmoid tumours.37 
Perioperative treatment 
Perioperative treatment is vital to improve 
the chances of success for surgery. Intestinal 
transplantation only came into frequent use 
in the early 1990s with the introduction of 
tacrolimus, an immunosuppressive agent 
that minimizes the risk of organ rejection.37 
Tacrolimus is used by itself or in 
conjunction with other immunosuppressors 
or corticosteroids.36 
Enteral nutrition is started as soon as 
possible after transplantation and an 
intestinal biopsy is performed every 48 
hours to detect signs of organ rejection. 
Finally, about 3 months after surgery and 
complete recovery, ileostomy closure is 
carried out and the central venous catheter 
is removed when the patient no longer relies 
on PN.36 
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Prognosis 
The prognosis for CIF patients receiving 
HPN is dependent on a number of factors, 
the most significant being the nature of the 
underlying disease.40 
In general, patients taking PN have a 1-year 
survival rate of 86%, which decreases to 
77% and 73% at 3 and 5 years, 
respectively.41A study was conducted to 
assess the clinical outcome in HPN patients 
with different underlying disorders. More 
than 80% of patients with CD, a non-
malignant disease, survived for 5 years or 
more, whilst only 20% of patients with 
cancer survived for 1 year or longer.42 In 
another study, it was found that PN patients 
with CD had a mean 10-year survival rate of 
88%, and those with intra-abdominal 
desmoids in familial polyposis had a variable 
outcome depending on the stage of the 
tumour.43 95%, 85%, and 65% of patients 
survived up to 10 years, for mild, moderate, 
and severe stage of disease respectively. Of 
all the underlying conditions, systemic 
sclerosis led to the poorest prognosis, with 
only 57% of patients surviving beyond 3 
years. 
Children commonly have a better outcome 
with PN than adults. In one study, it was 
shown that the probability of survival in 
children on PN, with various underlying 
conditions, amounted to 97%, 89%, and 
81% at 2, 5, and 10 years, respectively.40 
However, the majority of subjects in this 
study had primary digestive disorders (76%), 
which generally have a lower mortality rate 
than non-primary digestive disorders. Wales 
et al.44 investigated mortality among young 
children with SBS and in other surgical 
neonates. SBS patients had a fatality rate of 
37.5%, over 2 years, compared with 13.3% 
in patients undergoing surgery without SBS. 
In 2005, an observational study was 
published addressing the results of intestinal 
transplantation in patients with CIF. In a 
cohort of 923 patients with intestinal grafts, 
Grant et al.38 found a 1-year survival rate of 
81%. This is particularly encouraging 
because of the potential complications of 
intestinal transplantation, including 
significant expression of histocompatibility 
antigens and colonization with 
microorganisms.45,46 
Currently, there is an ongoing debate as to 
whether intestinal transplantation is as 
effective as HPN. The debate revolves 
around which category of patients may 
benefit from transplantation. In addition, 
the question remains as to how to select 
these patients and which facilities and 
experience should be present in the centres 
where they are treated. There may be a 
category of patients in which transplantation 
is superior to HPN. Examples are children 
with CIF combined with end-stage liver 
failure and in situations where chronic 
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access to the blood stream for PN has 
become impossible. 
Conclusion 
CIF, the long-term inability of the body to 
maintain a healthy internal environment 
through nutrition, can be caused by a variety 
of underlying malignant and non-malignant 
diseases. PN is a lifesaving therapy in the 
management of CIF and has significant 
beneficial effects on longevity and overall 
quality of life, despite being lower than in a 
healthy control group. We have explored the 
most recent literature on the physical, 
psychological, and social side effects of PN 
as a treatment for CIF, and compared it 
with other management strategies such as 
EN and bowel transplantation. Although 
PN is associated with a number of 
significant side effects such as infection, 
thrombophlebitis, and metabolic 
complications, it is currently the preferred 
method of nutritional support in patients 
whose bowel fails to absorb 
sufficientnutrients to maintain normal body 
composition and function. Combined 
enteral and parenteral nutrition does appear 
to have a similar or better prognosis than 
bowel transplantation.38,41-43 
Learning points 
What is already known 
 Chronic intestinal failure (CIF) is the long-term inability of the body to maintain a 
healthy internal environment through nutrition. 
 The nutritional need in CIF can be managed by enteral tube feeding, parenteral 
nutrition, or bowel transplant. 
 Each method of management is associated with several side effects and complications, 
some more serious than others. 
What this study adds 
 Where possible, enteral nutrition should be encouraged at all times as it can speed up 
the recovery process by physiologically stimulating the bowel and successfully covering 
the nutritional requirements with least side effects. 
 Parenteral nutrition, while associated with a number of significant physical, social, and 
psychological side effects, is the preferred method of nutritional support in patients 
whose bowel is not viable for enteral nutrition. 
 Bowel transplantation, although potentially curative, is associated with significant 
mortality and must be applied only in carefully selected cases.  
 Patients on long-term HPN are supported by a dedicated nutritional support team, who 
play a crucial role in supporting patients not only medically but also emotionally and 
mentally. 
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